Skip to main content
. 2023 Jan 30;13(1):e063896. doi: 10.1136/bmjopen-2022-063896

Table 1.

Clinical data and outcomes

Characteristics Total (n=1222) AKI (n=256) No AKI (n=966) P value
Age, years 57 (45–67) 63.5 (52–72) 55 (44–65) <0.001
Male, n (%) 666 (54.5) 151 (59.0) 515 (53.3) 0.105
BMI, kg/m2 22 (19.6–24.7) 22.3 (19.9–25.0) 21.9 (19.6–24.6) 0.395
Pre-existing clinical conditions
 Hypertension, n (%) 252 (20.6) 81 (31.6) 171 (17.7) <0.001
 Diabetes mellitus, n (%) 121 (9.9) 52 (20.3) 69 (7.1) <0.001
 Chronic kidney disease, n (%) 26 (2.1) 21 (8.2) 5 (0.5) <0.001
 Cerebrovascular disease, n (%) 127 (10.4) 50 (19.5) 77 (8.0) <0.001
 Chronic obstructive pulmonary disease, n (%) 35 (2.9) 18 (7.0) 17 (1.8) <0.001
 Coronary artery disease, n (%) 53 (4.3) 24 (9.4) 29 (3.0) <0.001
 Heart failure, n (%) 31 (2.5) 22 (8.6) 9 (0.9) <0.001
 Cancer, n (%) 227 (18.6) 50 (19.5) 177 (18.3) 0.659
Sepsis, n (%) 98 (8.0) 70 (27.3) 28 (2.9) <0.001
Admission type, n (%) <0.001
 Elective surgical, n (%) 863 (70.6) 84 (32.8) 779 (80.6)
 Emergency surgical, n (%) 83 (6.8) 33 (12.9) 50 (5.2)
 Medical, n (%) 276 (22.6) 139 (54.3) 137 (14.2)
Baseline serum creatinine, mg/dL 0.78 (0.64–0.96) 0.76 (0.58–1.09) 0.79 (0.65–0.94) 0.949
Baseline eGFR, mL/min/1.73 m2 119.4 (97.6–145.4) 122.9 (83.3–158.7) 118.7 (100.4–142.9) 0.950
Parameters at ICU admission
 sCr, mg/dL 0.87 (0.72–1.07) 0.97 (0.72–1.55) 0.85 (0.72–1.02) <0.001
 NT-proBNP, pg/mL 97.1 (29.4–464.4) 871.0 (225.8–2919.3) 66.2 (23.7–206.2) <0.001
 sCysC, mg/L 0.78 (0.61–1.06) 1.15 (0.83–1.85) 0.75 (0.58–0.94) <0.001
 APACHE Ⅱ score 7 (4–10) 11 (8–16) 6 (4–9) <0.001
UP, mL/kg/hour 1.67 (1.20–2.26) 1.37 (0.89–2.20) 1.73 (1.26–2.27) <0.001
Outcomes
 ICU mortality, n (%) 40 (3.3) 33 (12.9) 7 (0.7) <0.001
 In-hospital mortality, n (%) 53 (4.3) 40 (15.6) 13 (1.3) <0.001
 ICU stay, days 2 (2–4) 6 (3–13.3) 2 (2–3) <0.001
 Hospital stay, days 16 (12–23) 22 (13–33.3) 15 (11–21) <0.001
 ICU costs, CNY 39 461.7 (28 966.2–59 437.2) 66 140.1 (36 526.0–131 843.8) 37 667.5 (27 881.5–48 238.4) <0.001
 Total costs, CNY 58 295.3 (44 201.6–98 602.8) 128 945.6 (71 506.8–199 685.4) 52 773.8 (40 856.2–78 718.9) <0.001

Continuous variables are expressed as mean±SD or median (25th to 75th percentile, IQR). Categorical variables are expressed as a n (%).

AKI, acute kidney injury; BMI, body mass index; CNY, Chinese yuan; eGFR, estimated glomerular filtration rate; ICU, intensive care unit; NT-proBNP, N-terminal pro-B-type natriuretic peptide; APACHE Ⅱ score, Acute Physiology and Chronic Health Evaluation Ⅱ score; sCr, serum creatinine; sCysC, serum cystatin C; UP, urine production first 24 hours after admission.